Готові списки джерел за темами / Congenital Cardiovascular Disease

Зміст

  1. Статті в журналах
  2. Дисертації
  3. Книги
  4. Частини книг
  5. Тези доповідей конференцій

Добірка наукової літератури з теми "Congenital Cardiovascular Disease"

Автор: Grafiati
Опубліковано: 11 березня 2023

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Congenital Cardiovascular Disease".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Статті в журналах з теми "Congenital Cardiovascular Disease"

1

Kilner, P. "Congenital cardiovascular disease applications." Journal of Biomechanics 39 (January 2006): S288. http://dx.doi.org/10.1016/s0021-9290(06)84113-8.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Hlavacek, Anthony Marcus. "Imaging of Congenital Cardiovascular Disease." Journal of Thoracic Imaging 25, no. 3 (August 2010): 247–55. http://dx.doi.org/10.1097/rti.0b013e3181cc05e6.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Hanchard, Neil A., and Heather C. Mefford. "Editorial overview: Congenital cardiovascular disease." Current Opinion in Genetics & Development 77 (December 2022): 102006. http://dx.doi.org/10.1016/j.gde.2022.102006.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Bank, Estelle R. "MAGNETIC RESONANCE OF CONGENITAL CARDIOVASCULAR DISEASE." Radiologic Clinics of North America 31, no. 3 (May 1993): 553–72. http://dx.doi.org/10.1016/s0033-8389(22)02605-7.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Sakamoto, Takahiko. "Cardiovascular Surgery for Congenital Heart Disease." Pediatric Cardiology and Cardiac Surgery 31, no. 1-2 (2015): 39–51. http://dx.doi.org/10.9794/jspccs.31.39.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Bondy, Carolyn A. "Congenital Cardiovascular Disease in Turner Syndrome." Congenital Heart Disease 3, no. 1 (January 18, 2008): 2–15. http://dx.doi.org/10.1111/j.1747-0803.2007.00163.x.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Wooley, Charles F., and Elizabeth Henson Sparks. "Congenital heart disease, heritable cardiovascular disease, and pregnancy." Progress in Cardiovascular Diseases 35, no. 1 (July 1992): 41–60. http://dx.doi.org/10.1016/0033-0620(92)90034-w.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Egbe, Alexander C., William R. Miranda, Francisco Lopez-Jimenez, and Heidi M. Connolly. "Atherosclerotic Cardiovascular Disease in Adults With Congenital Heart Disease." JACC: Advances 1, no. 2 (June 2022): 100026. http://dx.doi.org/10.1016/j.jacadv.2022.100026.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Powell, AndrewJ, and JamesC Nielsen. "Cardiovascular MRI applications in congenital heart disease." Indian Journal of Radiology and Imaging 17, no. 2 (2007): 86. http://dx.doi.org/10.4103/0971-3026.33618.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Steiner, Robert M., Gautham P. Reddy, and Stephanie Flicker. "Congenital Cardiovascular Disease in the Adult Patient." Journal of Thoracic Imaging 17, no. 1 (January 2002): 1–17. http://dx.doi.org/10.1097/00005382-200201000-00001.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Дисертації з теми "Congenital Cardiovascular Disease"

1

Secchi, F. "CARDIOVASCULAR COMPUTED TOMOGRAPHY AND MAGNETIC RESONANCE IMAGING IN CONGENITAL HEART DISEASE." Doctoral thesis, Università degli Studi di Milano, 2017. http://hdl.handle.net/2434/470146.

Повний текст джерела
Анотація:
Cardiac magnetic resonance (CMR) is a non-invasive imaging modality highly reliable for studying cardiovascular morphology and function. Cardiac computed tomography (CCT) can give valuable anatomic information on CHD in children but implies radiation exposure, a relevant issue in children and newborns who are more radiosensitive than adult patients and have a longer lifetime to develop stochastic effects from radiation. We contributed to show the possibility to obtain an impressively low ionizing dose reduction in CHD patients also using standard 64-slice CT scanners. Conversely, CMR holds a pivotal role when functional and flow imaging is required. We showed the role of CMR in evaluating of patients percutaneously implanted with a pulmonary valve. Moreover, we proposed two new approaches for post-processing CMR images, regarding volume estimation of patients with a single ventricle, a rare CHD and a method for quantifying the paradoxical septal motion. CMR and CCT are two fundamental imaging techniques to evaluate patients with complex CHD. Both imaging modalities have limitations and advantages. CMR can evaluate heart function vessel flow but require a long acquisition time and in same patients a long sedation time. CCT has a very high spatial resolution and short acquisition time but implies ionizing radiation exposure. On the one side, we confirming the crucial role of CMR when function analysis is required but also showed the relevant possibilities of x-ray dose reduction in CCT, also using standard 64-slice scanners in the study of CHD patients.
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Lawley, Claire Margaret. "Outcomes in structural heart disease in New South Wales, Australia: From paediatrics to pregnancy." Thesis, The University of Sydney, 2018. http://hdl.handle.net/2123/20465.

Повний текст джерела
Анотація:
Aim To characterise and explore the contemporary outcomes at key points in the life of individuals in New South Wales (NSW), Australia, who have undergone a procedure for structural heart disease. Methods The population with structural heart disease was identified and outcomes at key points in life were evaluated using different methodologies; record linkage, retrospective cohort study and systematic review. Health and education outcomes of children with structural heart disease were evaluated via population-based record-linkage cohort studies. The role of advanced imaging methods in managing structural heart disease in paediatrics was evaluated via literature review. A retrospective cohort study was used to evaluate individuals who had undergone a percutaneous pulmonary valve implantation for structural heart disease. Health outcomes of women (and their offspring) who had undergone a prosthetic heart valve placement prior to pregnancy were evaluated using population-based record-linkage studies, systematic review and meta-analysis Results The main findings of this thesis include: -Structural heart disease in NSW requiring procedural management in the first year of life affects 2.5 per 1 000 births. Immediate health outcomes such as length of stay and mortality are similar to other centers. -Children who have had a cardiac procedure demonstrate a greater incidence of poor education outcome. Sociodemographic risk factors and ongoing health status are the major predictors of educational outcomes. -Novel imaging strategies can aid diagnosis, monitoring and management in complex structural heart disease. -Percutaneous pulmonary valve implantation, for rehabilitation of the right ventricular outflow tract in structural heart disease, has a low risk of a serious adverse event and shorter length of stay than historical surgical options. -The risk of severe maternal morbidity, a cardiovascular event, preterm birth and small-for-gestation age infants remains higher for women with a heart valve prosthesis than a pregnancy in the general population. Conclusions From early childhood to adult life, including child bearing years, individuals who have undergone a cardiac procedure for structural heart disease remain at risk of altered health status. This includes additional hospitalisations, maternal morbidity as well as adverse developmental and educational outcomes compared to the general population. Contemporary data demonstrates improvements in some domains. Evolution in multi-disciplinary, life-long care provides hope for further ameliorating outcomes.
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Murakami, Alexandre Noboru. "Impacto da parceria entre banco de dados internacional e centro único de cardiologia e cirurgia cardiovascular pediátrica de referência no Brasil." Faculdade de Medicina de São José do Rio Preto, 2018. http://hdl.handle.net/tede/418.

Повний текст джерела
Анотація:
Submitted by Suzana Dias (suzana.dias@famerp.br) on 2018-10-18T21:36:00Z No. of bitstreams: 1 AlexandreMurakami_dissert.pdf: 1293818 bytes, checksum: d98c26e3e45ebf6e17599765f2d44e2d (MD5)
Made available in DSpace on 2018-10-18T21:36:00Z (GMT). No. of bitstreams: 1 AlexandreMurakami_dissert.pdf: 1293818 bytes, checksum: d98c26e3e45ebf6e17599765f2d44e2d (MD5) Previous issue date: 2018-07-27
Developing countries have been dealing with several difficulties concerning congenital heart diseases. Among them is lack of control of results through some specific database. The participation in the International Quality Improvement Collaborative Database for Congenital Heart Disease (IQIC) - Improving care in low- and middle-income countries provides an opportunity to improve quality of care targeting morbidity and mortality reduction, facilitated by the establishment of parameters and objective data to evaluate treatment offered. Objective: To analyze factors in the International Quality Improvement Collaborative Database for Congenital Heart Disease (IQIC) database of a single center of cardiology and pediatric cardiovascular surgery that influenced the quality of care to patients with congenital heart disease. Casuistic and Methods: Data collection from January 2011 to December 2017 independently and with external audit by IQIC database partnership. Data included preoperative information such as demographic data, nutritional status, associated chromosomal abnormalities, Risk Adjustment for Congenital Heart Surgery (RACHS-1) score, as well as postoperative information such as infections, complications in the first 30 days or until hospital discharge and / or patient death. Results: In the preoperative period, there was a clear trend of increasing newborn patient cases, in detriment of those 1 to 18 years of age. There was a reduction in cases of malnutrition from 70% in 2013 to 55% in 2017. The postoperative period reveled significant variation between groups’ surgical procedures in RACHS-1 risk category (P= 0.003), prevalence of risk categories 2 and 3, as well as an increase in cases of risk categories 4,5 and 6, mainly in the last two years. Infection and mortality showed favorable results for reduction, with statistical significance for surgical site infection (P= 0.03), bacterial sepsis and other infections (both P <0.001). The 30-day postoperative follow-up showed a satisfactory evolution for discrete reduction in mortality, but not statistically significant difference in both in-hospital death (P=0.16) and 30 days (P=0.14). Conclusion: The analysis of the seven years of the IQIC database showed significant decrease in infection, increase in complexity of cases and reduction of mortality of patients with congenital heart disease in our environment.
Países em desenvolvimento enfrentam diversas dificuldades em relação às cardiopatias congênitas, dentre elas a falta de controle de resultados por meio de banco de dados específico. A participação no banco de dados International Quality Improvement Collaborative for Congenital Heart Disease (IQIC) - Improving care in low- and middle-income countries forneceu oportunidade de melhoria da qualidade na assistência para a redução de morbidade e mortalidade infantil, facilitada pelo estabelecimento de parâmetros e dados objetivos para avaliação de tratamentos oferecidos. Objetivo: Analisar os fatores do banco de dados International Quality Improvement Collaborative for Congenital Heart Disease (IQIC) – Improving care in low and middle income countries de um centro único de cardiologia e cirurgia cardiovascular pediátrica que influenciaram a qualidade de atendimento aos pacientes com cardiopatias congênitas. Casuística e Método: Coleta de dados no período de Janeiro de 2011 a Dezembro de 2017 de forma independente e com auditoria externa em parceria com banco de dados IQIC. Os dados incluíram informações pré-operatórias, tais como: dados demográficos, estado nutricional, síndromes associadas e categoria de risco cirúrgico (Risk Adjustment for Congenital Heart Surgery - RACHS-1), assim como, informações pós-operatórias como infecções, complicações nos primeiros 30 dias até a alta hospitalar e ou óbito do paciente. Resultados: No período pré-operatório, observou-se nítida tendência de aumento de casos de pacientes recém-nascidos em detrimento aos de 1 a 18 anos. Encontrou-se redução de casos com desnutrição de 70% em 2013 para 55% em 2017. No período pós-operatório os procedimentos cirúrgicos classificados na categoria de risco RACHS-1 revelaram variação significante entre os grupos (P=0,003), prevalecendo as categorias de grau 2 e 3, assim como, aumento de casos de categorias de risco 4,5 e 6, principalmente nos dois últimos anos do estudo. A infecção e mortalidade demonstraram resultados favoráveis para a redução, com significância estatística para infecção de sítio cirúrgico (P=0,03), sepse bacteriana e outras infecções (P<0,001). O acompanhamento de 30 dias de pós-operatório mostrou evolução satisfatória para discreta redução dos óbitos, porém sem diferença estatística tanto para morte intra-hospitalar (P=0,16) como em 30 dias (P=0,14). Conclusão: A análise dos sete anos do banco de dados IQIC permitiu demonstrar a diminuição significante de infecção, aumento da complexidade das doenças e redução da mortalidade dos pacientes com cardiopatias congênitas em nosso meio.
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Trairatvorakul, Pon. "Cardiovascular Safety of Stimulant Medication in Children with Congenital Heart Disease and Attention Deficit/Hyperactivity Disorder." University of Cincinnati / OhioLINK, 2016. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1459529300.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Milstone, Zachary J. "Histone Deacetylase 1 and 2 are Essential for Early Cardiac Development." eScholarship@UMMS, 2019. https://escholarship.umassmed.edu/gsbs_diss/1014.

Повний текст джерела
Анотація:
Congenital heart disease is the most common congenital anomaly, affecting approximately 1% of all live births each year. Although clinical interventions are improving, many affected infants do not survive to adulthood. Congenital cardiac defects originate from disturbances during development, making the study of mammalian cardiogenesis critical to improving outcomes for infants with congenital heart disease. Development of the mammalian heart involves epigenetically-driven specification and commitment of a diverse landscape of cardiac progenitors. Recent studies determined that chromatin modifying enzymes play a previously underappreciated role in the pathogenesis of congenital heart defects. This thesis investigates the functions of Hdac1 and Hdac2, highly homologous Class I histone deacetylases, during early murine cardiac development. We establish that Hdac1 and Hdac2 cooperatively regulate cardiogenesis in distinct cardiac progenitor populations during development. Together, our findings demonstrate that Hdac1 and Hdac2 are critical mediators of the earliest stages of mammalian cardiogenesis through a variety of spatiotemporally specific, redundant, and dose-sensitive roles and indicate they may play important roles in the pathogenesis of human congenital cardiac defects.
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Carreira, Vinicius S. "The Aryl Hydrocarbon Receptor Contributions to Cardiovascular Development and Health." University of Cincinnati / OhioLINK, 2015. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1446547352.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Häcker, Anna-Luisa [Verfasser], Renate [Akademischer Betreuer] Oberhoffer-Fritz, Renate [Gutachter] Oberhoffer-Fritz, and Martin [Gutachter] Klingenspor. "Cardiovascular risk in patients with congenital heart disease / Anna-Luisa Häcker ; Gutachter: Renate Oberhoffer-Fritz, Martin Klingenspor ; Betreuer: Renate Oberhoffer-Fritz." München : Universitätsbibliothek der TU München, 2020. http://d-nb.info/1213026105/34.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Ebrahimi, Pegah. "Patient-specific design of the right ventricle to pulmonary artery conduit via computational analysis." Thesis, The University of Sydney, 2019. http://hdl.handle.net/2123/20381.

Повний текст джерела
Анотація:
Cardiovascular prostheses are routinely used in surgical procedures to address congenital malformations, for example establishing a pathway from the right ventricle to the pulmonary arteries (RV-PA) in pulmonary atresia and truncus arteriosus. Currently available options are fixed size and have limited durability. Hence, multiple re-operations are required to match the patients’ growth and address structural deterioration of the conduit. Moreover, the pre-set shape of these implants increases the complexity of operation to accommodate patient specific anatomy. The goal of the research group is to address these limitations by 3D printing geometrically customised implants with growth capacity. In this study, patient-specific geometrical models of the heart were constructed by segmenting MRI data of patients using Mimics inPrint 2.0. Computational Fluid Dynamics (CFD) analysis was performed, using ANSYS CFX, to design customised geometries with better haemodynamic performance. CFD simulations showed that customisation of a replacement RV-PA conduit can improve its performance. For instance, mechanical energy dissipation and wall shear stress can be significantly reduced. Finite Element modelling also allowed prediction of the suitable thickness of a synthetic material to replicate the behaviour of pulmonary artery wall under arterial pressures. Hence, eliminating costly and time-consuming experiments based on trial-and-error. In conclusion, it is shown that patient-specific design is feasible, and these designs are likely to improve the flow dynamics of the RV-PA connection. Modelling also provides information for optimisation of biomaterial. In time, 3D printing a customised implant may simplify replacement procedures and potentially reduce the number of operations required over a life time, bringing substantial improvements in quality of life to the patients
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Pham, Hoang Minh [Verfasser]. "Cardiovascular Magnetic Resonance Imaging in the Assessment of Myocardial Blood Flow, Viability, and Diffuse Fibrosis in Congenital and Acquired Heart Disease / Hoang Minh Pham." Kiel : Universitätsbibliothek Kiel, 2014. http://d-nb.info/1052893724/34.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

McDonald, Cameron. "Investigations in Cardiac Development and Cardiac Regeneration." Thesis, Griffith University, 2009. http://hdl.handle.net/10072/366063.

Повний текст джерела
Анотація:
Cardiovascular disease and congenital heart disease impose a massive burden on society around the world. From the cost in terms of lost human lives and diminished quality of life, to the financial expense of ongoing medical treatment, the heart’s inability to effectively repair and regenerate itself presents a major challenge for medical research. The research conducted within this thesis hoped to contribute to our knowledge of the molecular pathways of myocardial development, and to explore the potential of olfactory derived stem cells to repopulate insulted myocardium. A combination of molecular biology and classical embryology techniques were first used to characterise two novel cDNAs identified in an earlier study as being upregulated in the regions of cardiac development within the chick embryo. cDNA and genomic library screening along with RACE (rapid amplification of cDNA ends) produced products which were sequenced to identify both the transcript and genomic sequence for both of the genes. Protein expression constructs were then used to identify the localisation of the encoded proteins, and whole mount in situ hybridisation utilised to identify the temporal and spatial expression patterns of the genes. The first cDNA was identified as the vertebrate homologue of the Drosophila e(y)2 gene, and produces a transcript of approximately 600 bp in the chick with a genomic structure consisting of 5 exons covering approximately 6 Kb. The encoded protein localises to the nucleus. Its expression is ubiquitous both temporally and spatially, which is at odds with its initial method of identification. The second cDNA remains novel at the time of submission, and shows no homology to any characterised genes. This cDNA, named C1-3C, produces two alternative transcripts, one of approximately 700 bp, and a second of 9.9 Kb, with a genomic structure showing no introns within the 2 Kb of analysed sequence. The encoded protein again localises to the nucleus. Expression of the C1-3C gene demonstrated a discrete pattern, though this pattern is again contrary to an up-regulation within the cardiogenic regions. Whilst unfortunately neither of the investigated genes appear to play a direct role in cardiac development, the aim of characterisation of these novel cDNAs was achieved.
Thesis (PhD Doctorate)
Doctor of Philosophy (PhD)
School of Biomolecular and Physical Sciences
Science, Environment, Engineering and Technology
Full Text
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Книги з теми "Congenital Cardiovascular Disease"

1

Yasui, Hisataka, Hideaki Kado, and Munetaka Masuda, eds. Cardiovascular Surgery for Congenital Heart Disease. Tokyo: Springer Japan, 2009. http://dx.doi.org/10.1007/978-4-431-99470-1.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Sridharan, Shankar, Gemma Price, Oliver Tann, Marina Hughes, Vivek Muthurangu, and Andrew M. Taylor. Cardiovascular MRI in Congenital Heart Disease. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-540-69837-1.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Yasui, Hisataka. Cardiovascular surgery for congenital heart disease. Tokyo: Springer, 2009.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

S, Rosenbaum Marlon, and Anyane-Yeboa Kwame, eds. Congenital heart disease in adults. New York: McGraw-Hill, Medical Pub. Division, 2002.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Mascia, Pierpont Mary Ella, and Moller James H. 1933-, eds. The genetics of cardiovascular disease. Boston: Nijhoff, 1987.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

D, Tonkin Ina L., ed. Pediatric cardiovascular imaging. Philadelphia, PA: Saunders, 1992.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Cardiovascular MRI in congenital heart disease: An imaging atlas. Heidelberg: Springer, 2010.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Sridharan, Shankar. Cardiovascular MRI in congenital heart disease: An imaging atlas. Heidelberg: Springer, 2010.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Nakanishi, Toshio. Molecular Mechanism of Congenital Heart Disease and Pulmonary Hypertension. Singapore: Springer Nature, 2020.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Rychik, Jack, and Zhiyun Tian. Fetal cardiovascular imaging: A disease based approach. Philadelphia, PA: Saunders/Elsevier, 2011.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Частини книг з теми "Congenital Cardiovascular Disease"

1

Stern, Joshua A. "Congenital Cardiovascular Disease." In Textbook of Small Animal Emergency Medicine, 325–28. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2018. http://dx.doi.org/10.1002/9781119028994.ch52.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Galve-Basilio, E. "Congenital heart disease." In Developments in Cardiovascular Medicine, 282–94. Dordrecht: Springer Netherlands, 1994. http://dx.doi.org/10.1007/978-94-011-1984-9_15.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Wald, Rachel M., and Andrew J. Powell. "Congenital Heart Disease." In Cardiovascular Magnetic Resonance Imaging, 537–65. Totowa, NJ: Humana Press, 2008. http://dx.doi.org/10.1007/978-1-59745-306-6_25.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Boxt, Lawrence M., and Laureen M. Sena. "Imaging Congenital Cardiovascular Disease." In Diseases of the Heart and Chest, Including Breast 2011–2014, 168–76. Milano: Springer Milan, 2011. http://dx.doi.org/10.1007/978-88-470-1938-6_25.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Ward, Cary, J. Kevin Harrison, and Thomas M. Bashore. "Adult Congenital Heart Disease." In Cardiovascular Clinical Trials, 274–95. Oxford, UK: Blackwell Publishing Ltd., 2012. http://dx.doi.org/10.1002/9781118399378.ch10.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Pillutla, Priya, and Jamil A. Aboulhosn. "Congenital Heart Disease." In Atlas of Cardiovascular Computed Tomography, 339–50. London: Springer London, 2017. http://dx.doi.org/10.1007/978-1-4471-7357-1_17.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Kovacs, Adrienne H., and Graham J. Reid. "Congenital Heart Disease." In Handbook of Cardiovascular Behavioral Medicine, 1227–46. New York, NY: Springer New York, 2022. http://dx.doi.org/10.1007/978-0-387-85960-6_51.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Aoki-Kamiya, Chizuko. "Congenital Heart Disease." In Maternal and Fetal Cardiovascular Disease, 163–77. Singapore: Springer Singapore, 2018. http://dx.doi.org/10.1007/978-981-10-1993-7_14.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Kalmar, Jayne M., Brigid M. Lynch, Christine M. Friedenreich, Lee W. Jones, A. N. Bosch, Alessandro Blandino, Elisabetta Toso, et al. "Congenital Cardiovascular Malformations." In Encyclopedia of Exercise Medicine in Health and Disease, 204. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-540-29807-6_4128.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Yue, Patrick. "Congenital Heart Disease." In A Practical Approach to Cardiovascular Medicine, 225–38. Oxford, UK: Wiley-Blackwell, 2011. http://dx.doi.org/10.1002/9781444393897.ch18.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "Congenital Cardiovascular Disease"

1

Mesihović-Dinarević, Senka. "UPDATE IN DIAGNOSTICS CARDIOLOGY." In International Scientific Symposium “Diagnostics in Cardiology and Grown-Up Congenital Heart Disease (GUCH)”. Academy of Sciences and Arts of Bosnia and Herzegovina, 2021. http://dx.doi.org/10.5644/pi2021.199.02.

Повний текст джерела
Анотація:
Cardiovascular medicine is an area of clinical practice with a continually rapid expansion of knowledge, guidelines, best practices and new technology in adult cardiovascular medicine as well as in paediatric cardiology medicine. Cardiovascular diseases (CVD) are the leading cause of mortality in the world and cause major costs for the health sector and economy. Cardiovascular imaging indices have a significant impact on the prevention, diagnosis, and treatment of cardiac diseases. Advanced imaging technologies have dramatically improved our ability to detect and treat cardiovascular disease at an early stage. Multimodality imaging techniques - echocardiogram, cardiac computerized tomography, magnetic resonance imaging, simulation 3D models, artificial intelligence - are being used more frequently as their utility is better appreciated. Coronavirus disease 2019 (COVID-19) exerts an unprecedented global impact on public health and health care delivery. Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) causing COVID-19 has reached pandemic levels since March 2020. Patients with cardiovascular (CV) risk factors and established CVD represent a vulnerable population when suffering from COVID-19, and have an increased risk of morbidity and mortality. Severe COVID-19 infection is associated with myocardial damage and cardiac arrhythmia. Diagnostic workup during SARS infection revealed electrocardiographic changes, sub-clinical left ventricular (LV) diastolic impairment and troponin elevation. All professionals in cardiovascular medicine, as a part of lifelong learning process, have the continuous imperative in reviewing novelties, with results data from numerous researches in order to treat all patients according to best practices and evidence-based medicine, especially on this journey through corona pandemic.
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Petersen, J., Y. Yildirim, T. Tönnis, H. Reichenspurner, and S. Pecha. "Transvenous Lead Extraction in Patients with Grownup Congenital Heart Disease." In 50th Annual Meeting of the German Society for Thoracic and Cardiovascular Surgery (DGTHG). Georg Thieme Verlag KG, 2021. http://dx.doi.org/10.1055/s-0041-1725711.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Spracklen, Timothy, Thomas Aldersley, Nicole Saacks, Bianca de Koning, John Lawrenson, Paul Human, James Eales, et al. "BS26 The partnerships in congenital heart disease in africa study (PROTEA): clinical characteristics and genetic findings from a South African congenital heart disease cohort." In British Cardiovascular Society Virtual Annual Conference, ‘Cardiology and the Environment’, 7–10 June 2021. BMJ Publishing Group Ltd and British Cardiovascular Society, 2021. http://dx.doi.org/10.1136/heartjnl-2021-bcs.224.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Mesihović-Dinarević, Senka. "WHAT IS NEW IN CARDIOVASCULAR MEDICINE?" In Symposium with International Participation HEART AND … Akademija nauka i umjetnosti Bosne i Hercegovine, 2019. http://dx.doi.org/10.5644/pi2019.181.03.

Повний текст джерела
Анотація:
The rapid pace of change continues to be a hallmark in cardiovascular medicine and many see that pace accelerating in adult cardiovascular medicine as well as in paediatric cardiology medicine. Cardiovascular medicine is an area of clinical practice with a continually rapid expansion of knowledge, guidelines, best practices and new technology. Cardiovascular diseases are the leading cause of mortality in the world and cause major costs for the health sector and economy. Primary care clinicians are challenged to optimally manage a multitude of diseases including congestive heart failure, coronary artery disease, valvular diseases, arrhythmias, lipid disorders, and hypertension. Multimodality imaging techniques are being used more frequently as their utility is better appreciated. Echocardiography has been the mainstay approach, cardiac computerized tomography and magnetic resonance imaging provide a good imaging alternative for patients with multiple complex surgeries. 3D printing has seen a rapid growth in use for planning treatments for patients with congenital heart disease. Simulation using 3D models is emerging as a fundamental resource for teaching procedural techniques and a new standard of care. Artificial intelligence holds the greatest potential for revolutionizing medicine. Innovative technologies in the world of cardiovascular health are expanding every day: wearable computing technologies, bioresorbable stents, leadless pacemaker, valve-in-valve procedure, protein patch for heart muscle growth and others. As a part of lifelong learning process for all professionals in cardiovascular medicine, the imperative is to have continuity of reviewing novelties, with results data from numerous researches in order to treat patient according to best practices and evidence-based medicine.
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Baross, Stephanie, Simon Williams, Kathryn Hentges, Andrew Sharrocks, and Bernard Keavney. "BS54 Variation in cardiac long non-coding rnas in congenital heart disease." In British Cardiovascular Society Annual Conference ‘Digital Health Revolution’ 3–5 June 2019. BMJ Publishing Group Ltd and British Cardiovascular Society, 2019. http://dx.doi.org/10.1136/heartjnl-2019-bcs.215.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Raza, Sadaf, Damien Cullington, and Matthew J. Daniels. "27 Utilisation of genetic testing in an adult congenital heart disease clinic." In British Cardiovascular Society Annual Conference, ‘100 years of Cardiology’, 6–8 June 2022. BMJ Publishing Group Ltd and British Cardiovascular Society, 2022. http://dx.doi.org/10.1136/heartjnl-2022-bcs.27.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Bremer, S. J., A. Boxnick, D. Biermann, L. Glau, P. A. Hauck, E. Billeb, M. I. Fortmann, E. Tolosa, J. S. Sachweh, and A. Gieras. "Impaired Early T-Cell Development in Infants with Complex Congenital Heart Disease." In 51st Annual Meeting of the German Society for Thoracic and Cardiovascular Surgery (DGTHG). Georg Thieme Verlag KG, 2022. http://dx.doi.org/10.1055/s-0042-1742903.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Boethig, D., M. Avsar, U. Bauer, P. Beerbaum, F. Berger, R. Cesnjevar, I. Dähnert, et al. "Lifetime Endocarditis Risk with Congenital Heart Disease and Pulmonary Valve Prosthesis (PVP): Results from the German Registry for Congenital Heart Defects (CHD)." In 51st Annual Meeting of the German Society for Thoracic and Cardiovascular Surgery (DGTHG). Georg Thieme Verlag KG, 2022. http://dx.doi.org/10.1055/s-0042-1742863.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Joy, Eleanor, and Kate English. "26 Cerebral abscess in adult congenital heart disease (achd): a single centre experience." In British Cardiovascular Society Annual Conference, ‘100 years of Cardiology’, 6–8 June 2022. BMJ Publishing Group Ltd and British Cardiovascular Society, 2022. http://dx.doi.org/10.1136/heartjnl-2022-bcs.26.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Evers, Patrick D., Dora Farkas, Cathrine Hjorth, Michael Khoury, and Nicolas Madsen. "Return to Work Characteristics Following Adverse Cardiovascular Events in Adults with Congenital Heart Disease." In AAP National Conference & Exhibition Meeting Abstracts. American Academy of Pediatrics, 2021. http://dx.doi.org/10.1542/peds.147.3_meetingabstract.393.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Також вас можуть зацікавити розширені добірки на тему "Congenital Cardiovascular Disease" для конкретних типів джерел:
Статті в журналах Дисертації Книги
Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!

До бібліографії